Literature DB >> 22136428

Biology and significance of signalling pathways activated by IGF-II.

Lynda K Harris1, Melissa Westwood.   

Abstract

Insulin-like growth factor-II (IGF-II) affects many aspects of cellular function through its ability to activate several different receptors and, consequently, numerous intracellular signalling molecules. Thus, IGF-II is a key regulator of normal foetal development and growth. However, abnormalities in IGF-II function are associated with cardiovascular disease and cancer. Here, we review the cellular mechanisms by which IGF-II's physiological and pathophysiological actions are exerted by discussing the involvement of the type 1 and type 2 IGF receptors (IGF1R and IGF2R), the insulin receptor and the downstream MAP kinase, PI-3 kinase and G-protein-coupled signalling pathways in mediating IGF-II stimulated cellular proliferation, survival, differentiation and migration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136428     DOI: 10.3109/08977194.2011.640325

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  26 in total

1.  Cooperative Repression of Insulin-Like Growth Factor Type 2 Receptor Translation by MicroRNA 195 and RNA-Binding Protein CUGBP1.

Authors:  Yuan Zhang; Yun Zhang; Lan Xiao; Ting-Xi Yu; Jun-Zhe Li; Jaladanki N Rao; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Mol Cell Biol       Date:  2017-09-12       Impact factor: 4.272

Review 2.  Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth.

Authors:  Amanda N Sferruzzi-Perri; Ionel Sandovici; Miguel Constancia; Abigail L Fowden
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

3.  IGF-binding proteins 3 and 4 are regulators of sprouting angiogenesis.

Authors:  Marchien G Dallinga; Yasmin I Habani; Richelle P Kayser; Cornelis J F Van Noorden; Ingeborg Klaassen; Reinier O Schlingemann
Journal:  Mol Biol Rep       Date:  2020-03-04       Impact factor: 2.316

4.  IGF-2R-Gαq signaling and cardiac hypertrophy in the low-birth-weight lamb.

Authors:  Kimberley C W Wang; Darran N Tosh; Song Zhang; I Caroline McMillen; Jaime A Duffield; Doug A Brooks; Janna L Morrison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-01-28       Impact factor: 3.619

5.  Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.

Authors:  Adetunji T Toriola; Mark Ziegler; Yize Li; Michael Pollak; Rachael Stolzenberg-Solomon
Journal:  Ann Surg Oncol       Date:  2017-07-05       Impact factor: 5.344

6.  Insulin-like growth factor-2 enhances functions of antigen (Ag)-specific regulatory B cells.

Authors:  Xiao-Rui Geng; Gui Yang; Meng Li; Jiang-Ping Song; Zhi-Qiang Liu; Shuqi Qiu; Zhigang Liu; Ping-Chang Yang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

7.  Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.

Authors:  Daniel Portal; Hufeng Zhou; Bo Zhao; Peter V Kharchenko; Elizabeth Lowry; Limsoon Wong; John Quackenbush; Dustin Holloway; Sizun Jiang; Yong Lu; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

8.  A CCR2+ myeloid cell niche required for pancreatic β cell growth.

Authors:  Kristin Mussar; Stephanie Pardike; Tobias M Hohl; Gary Hardiman; Vincenzo Cirulli; Laura Crisa
Journal:  JCI Insight       Date:  2017-08-03

9.  A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling.

Authors:  Ling Lin; Lynn Chamberlain; Magnolia L Pak; Arvindhan Nagarajan; Romi Gupta; Lihua J Zhu; Casey M Wright; Kwun M Fong; Narendra Wajapeyee; Michael R Green
Journal:  Cancer Discov       Date:  2014-07-11       Impact factor: 39.397

10.  Insulin-Like Growth Factor-2 Is Induced Following 5-Aminolevulinic Acid-Mediated Photodynamic Therapy in SW620 Human Colon Cancer Cell Line.

Authors:  Marta Woźniak; Kamila Duś-Szachniewicz; Piotr Ziółkowski
Journal:  Int J Mol Sci       Date:  2015-10-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.